Tag:
Supreme Court
Latest Headlines
Latest Headlines
Supreme Court zeroes in on pharma reps' OT claims
Will pharma reps' crusade for overtime pay survive the U.S. Supreme Court?
UPDATED: Supreme Court upholds Unigene's nasal delivery patent
Unigene Laboratories can hold on to its patent for Fortical, after the Supreme Court denied Apotex's petition this week.
Supreme Court hears patent-description fight
The U.S. Supreme Court has the chance to make it easier for generics makers to fight against certain patent protections--or to make sure branded drugmakers have to face certain challenges at all. The
Public Citizen: FDA should change generics labeling rules
Public Citizen is asking the FDA to change its rules and allow generic drugmakers to update the labeling on their products. The change would address a recent U.S. Supreme Court ruling that generics
GSK reps take OT suit to U.S. Supreme Court
The U.S. Supreme Court may just decide this pharma-rep overtime issue once and for all. Two GlaxoSmithKline ( $GSK ) reps who lost their suit for back overtime pay on appeal are asking the Supremes to
S-P sales reps win another OT round
Chalk up another victory for sales reps in their fight for overtime pay. A U.S. judge has decided that Schering-Plough sales people don't qualify for the administrative exemption under U.S. labor
High court ruling stalls generics liability suits
The U.S. Supreme Court's recent ruling in a generics-labeling case, which offers a new shield against liability for safety warnings, has thrown a wrench into thousands of pending lawsuits and class
Judge deems Boehringer rep eligible for OT pay
Time to update your sales-rep overtime scorecard. A federal judge has ruled that a Boehringer Ingelheim rep is not exempt from overtime pay under the Fair Labor Standards Act, Pharmalot reports. It's
Supreme Court backs Lilly in Zyprexa class action
Eli Lilly has gotten a break from the U.S. Supreme Court. The justices nixed an appeal in a proposed class action over Zyprexa. The group of plaintiffs--including pension funds, unions and
High court rules against Vermont in data-mining case
The Supreme Court ruled 6-3 Thursday that states may not prohibit the use of information about physician healthcare practices in the marketing of medicines. The decision strikes down a Vermont law
